Valuation: CEREP

Market Cap 91.3M 102M 85.18M 77.37M 146M 9.88B 147M 1.02B 400M 5.03B 384M 375M 16.16B P/E 2024 *
-
P/E 2025 -
Enterprise Value 70.26M 78.64M 65.55M 59.54M 112M 7.61B 113M 788M 308M 3.87B 295M 289M 12.44B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+4.16%+4.16%+49.37%+94.17% 74.68B
-18.36%-18.82%-0.58%+46.30% 58.7B
-1.52%+1.46%+4.41%+32.59% 48.36B
+0.50%-2.14%+331.33%+702.20% 43.05B
-0.72%-3.99%+28.50%+29.94% 42.48B
+0.34%-0.52%+6.56%+109.35% 41.39B
-0.11%+1.96%+9.19%+52.66% 31.29B
-0.50%-3.10%-10.19%-14.35% 23.93B
-3.32%-10.86%-37.32%+316.28% 22.22B
Average -2.19%-2.18%+42.36%+152.13% 42.9B
Weighted average by Cap. -2.42%-1.56%+48.76%+144.23%

Financials

2024 2025
Net sales 40.49M 45.31M 37.77M 34.31M 64.62M 4.38B 65.1M 454M 177M 2.23B 170M 166M 7.17B 41.1M 46M 38.34M 34.83M 65.59M 4.45B 66.08M 461M 180M 2.26B 173M 169M 7.27B
Net income 7.15M 8.01M 6.67M 6.06M 11.42M 775M 11.5M 80.21M 31.34M 394M 30.06M 29.41M 1.27B 4.78M 5.35M 4.46M 4.05M 7.63M 518M 7.69M 53.62M 20.95M 263M 20.09M 19.66M 847M
Net Debt -17.25M -19.31M -16.1M -14.62M -27.54M -1.87B -27.74M -193M -75.57M -950M -72.49M -70.92M -3.05B -21.03M -23.54M -19.62M -17.83M -33.57M -2.28B -33.82M -236M -92.13M -1.16B -88.38M -86.47M -3.72B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-